Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review
Authors
Keywords
-
Journal
PROGRESS IN LIPID RESEARCH
Volume 91, Issue -, Pages 101240
Publisher
Elsevier BV
Online
2023-07-19
DOI
10.1016/j.plipres.2023.101240
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models
- (2023) Yanli Lu et al. Obesity
- The role of irisin and asprosin level in the pathophysiology of prediabetes
- (2023) Gokcen Nailer Ertuna et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Asprosin Enhances Cytokine Production by a Co-Culture of Fully Differentiated Mature Adipocytes and Macrophages Leading to the Exacerbation of the Condition Typical of Obesity-Related Inflammation
- (2023) Agnieszka I. Mazur-Bialy INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular cloning, characterization and 3D modelling of spotted snakehead fbn1 C-terminal region encoding asprosin and expression analysis of fbn1
- (2023) Priyanka Sathoria et al. Scientific Reports
- Acute effect of moderate and high-intensity interval exercises on asprosin and BDNF levels in inactive normal weight and obese individuals
- (2023) Halil İbrahim Ceylan et al. Scientific Reports
- Asprosin promotes feeding through SK channel–dependent activation of AgRP neurons
- (2023) Bing Feng et al. Science Advances
- Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
- (2022) Yousef A. T. Morcos et al. Scientific Reports
- Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy
- (2022) Thorben Hoffmann et al. Endocrine Connections
- Association of maternal and umbilical cord blood asprosin with excessive gestational weight gain
- (2022) Fatemeh Behrasi et al. NUTRITION BULLETIN
- Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease
- (2022) Mei You et al. Cardiovascular Diabetology
- Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor
- (2022) Ila Mishra et al. Cell Metabolism
- A cross-sectional comparative study on the effects of body mass index and exercise/sedentary on serum asprosin in male college students
- (2022) Ruiqi Huang et al. PLoS One
- Designing antibodies as therapeutics
- (2022) Paul J. Carter et al. CELL
- Association between circulating Asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes
- (2022) Xia Deng et al. CLINICAL BIOCHEMISTRY
- Asprosin modulates testicular functions during ageing in mice
- (2022) Sangeeta Maurya et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway
- (2022) Jin Zou et al. Journal of Translational Medicine
- Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy
- (2022) Hasan Cantay et al. Obesity
- Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
- (2022) Andre Lima Queiroz et al. Nature Communications
- Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study
- (2022) Linxin Xu et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Asprosin promotes steroidogenesis and spermatogenesis with improved glucose metabolism in adult mice testis
- (2022) Sangeeta Maurya et al. ANDROLOGIA
- Asprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production
- (2022) Xiao-Li Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus
- (2022) Chenggang Dai et al. MEDICINE
- Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables
- (2022) Katarzyna Jowik et al. Nutrients
- Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
- (2022) Tingting Yao et al. Frontiers in Physiology
- Asprosin Exacerbates Endothelium Inflammation Induced by Hyperlipidemia Through Activating IKKβ-NF-κBp65 Pathway
- (2022) Qianqian Huang et al. INFLAMMATION
- Angiogenesis–Browning Interplay Mediated by Asprosin-Knockout Contributes to Weight Loss in Mice with Obesity
- (2022) Tingting Yin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
- (2022) Kiran Shabir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin, Leptin and Cardiovascular Disorders
- (2021) Shangang Zhao et al. CIRCULATION RESEARCH
- Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue
- (2021) Yanli Miao et al. JOURNAL OF ENDOCRINOLOGY
- Association of serum asprosin concentrations with obstructive sleep apnea syndrome
- (2021) Jurong Ding et al. Sleep and Breathing
- High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
- (2021) Tao Hong et al. International Journal of Endocrinology
- Neuroscientific Therapies for Atrial Fibrillation
- (2021) Peter Hanna et al. CARDIOVASCULAR RESEARCH
- The sympathetic nervous system and ventricular arrhythmias: an inseparable union
- (2021) Filippo Maria Cauti et al. EUROPEAN HEART JOURNAL
- Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease
- (2021) Hao-Hua Wang et al. PHYSIOLOGICAL RESEARCH
- Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
- (2021) Aijun Jiang et al. Diabetology & Metabolic Syndrome
- Increased serum asprosin is correlated with diabetic nephropathy
- (2021) Rui Wang et al. Diabetology & Metabolic Syndrome
- CENTRAL AND PERIPHERAL SYMPATHETIC ACTIVATION IN HEART FAILURE
- (2021) Guido Grassi et al. CARDIOVASCULAR RESEARCH
- Asprosin serum levels and glucose homeostasis in children with obesity
- (2021) Domenico Corica et al. CYTOKINE
- Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
- (2021) Kiran Shabir et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases
- (2021) Monika Barteková et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study
- (2021) Nariman Moradi et al. Lipids in Health and Disease
- Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy
- (2021) Golnoosh Goodarzi et al. MOLECULAR BIOLOGY REPORTS
- Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
- (2021) Suowen Xu et al. PHARMACOLOGICAL REVIEWS
- Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity
- (2021) Lu-Jie Liu et al. World Journal of Pediatrics
- Nordic Walking at Maximal Fat Oxidation Intensity Decreases Circulating Asprosin and Visceral Obesity in Women With Metabolic Disorders
- (2021) Malgorzata Kantorowicz et al. Frontiers in Physiology
- Marfan syndrome
- (2021) Dianna M. Milewicz et al. Nature Reviews Disease Primers
- A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes
- (2021) Hoonsik Nam et al. JNCI-Journal of the National Cancer Institute
- Intracerebroventricular asprosin administration strongly stimulates hypothalamic-pituitary-testicular axis in rats
- (2021) Tuba Keskin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A potential role of fibrillin-1 (FBN1) mRNA and asprosin in follicular development in water buffalo
- (2021) Excel Rio S. Maylem et al. THERIOGENOLOGY
- Caudamins, a new subclass of protein hormones
- (2021) Bijoya Basu et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?
- (2020) G. Eser Karlidag et al. BIOTECHNIC & HISTOCHEMISTRY
- Increased Serum Circulating Asprosin Levels in Children with Obesity
- (2020) Eda Sünnetçi Silistre et al. PEDIATRICS INTERNATIONAL
- ALTERED BLOOD AND AQUEOUS HUMOR LEVELS OF ASPROSIN, 4-HYDROXYNONENAL, AND 8-HYDROXY-DEOXYGUANOSINE IN PATIENTS WITH DIABETES MELLITUS AND CATARACT WITH AND WITHOUT DIABETIC RETINOPATHY
- (2020) Yavuz Oruc et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The modulatory effects of irisin on asprosin, leptin, glucose levels and lipid profile in healthy and obese male and female rats
- (2020) Sibel Ozcan et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Placensin is a glucogenic hormone secreted by human placenta
- (2020) Yiping Yu et al. EMBO REPORTS
- Targeting cardiovascular inflammation: next steps in clinical translation
- (2020) Patrick R Lawler et al. EUROPEAN HEART JOURNAL
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease
- (2020) Hongyu Zhang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study
- (2020) Lieqiang Zhong et al. PLACENTA
- Asprosin promotes β‐cell apoptosis by inhibiting the autophagy of β‐cell via AMPK‐mTOR pathway
- (2020) Rui Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin is associated with anorexia and body fat mass in cancer patients
- (2020) Cheng Du et al. SUPPORTIVE CARE IN CANCER
- Serum concentration of asprosin in new-onset type 2 diabetes
- (2020) Shakiba Naiemian et al. Diabetology & Metabolic Syndrome
- The role of Asprosin in patients with dilated cardiomyopathy
- (2020) Ming-Shien Wen et al. BMC Cardiovascular Disorders
- Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men
- (2020) Halil İbrahim Ceylan et al. CHRONOBIOLOGY INTERNATIONAL
- Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease
- (2020) Fan Ke et al. CYTOKINE
- Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin
- (2020) Nevzat Gozel et al. Endokrynologia Polska
- Discovery of a possible role of asprosin in ovarian follicular function
- (2020) Excel Rio S Maylem et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Expression of asprosin in rat hepatic, renal, heart, gastric, testicular and brain tissues and its changes in a streptozotocin-induced diabetes mellitus model
- (2020) Nevin Kocaman et al. TISSUE & CELL
- Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women
- (2020) A. N. Leonard et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
- (2020) Hidetaka Wakabayashi et al. Journal of Cachexia Sarcopenia and Muscle
- Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK
- (2020) Yunhua Zhang et al. ENZYME AND MICROBIAL TECHNOLOGY
- Maternal exposure to air pollution and umbilical asprosin concentration, a novel insulin-resistant marker
- (2020) Zeynab Sadat Hosseini et al. CHEMOSPHERE
- PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes
- (2019) George R. Uhl et al. Annals of the New York Academy of Sciences
- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Sedentary Behavior, Exercise, and Cardiovascular Health
- (2019) Carl J. Lavie et al. CIRCULATION RESEARCH
- Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
- (2019) Matthias von Herrath et al. Cell Metabolism
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Adverse organogenesis and predisposed long-term metabolic syndrome from prenatal exposure to fine particulate matter
- (2019) Guoyao Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
- (2019) Chia Lin Chang et al. Scientific Reports
- Aerobic Exercise Training Decreases Hepatic Asprosin in Diabetic Rats
- (2019) Jeong Rim Ko et al. Journal of Clinical Medicine
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Decreased Circulating Levels of Asprosin in Obese Children
- (2019) Wenjun Long et al. Hormone Research in Paediatrics
- Renal Denervation Update From the International Sympathetic Nervous System Summit
- (2019) Márcio G. Kiuchi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The endocrine function of adipose tissues in health and cardiometabolic disease
- (2019) Ludger Scheja et al. Nature Reviews Endocrinology
- Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway
- (2019) Zhengbin Zhang et al. LIFE SCIENCES
- Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes
- (2019) Jan Benedikt Groener et al. PLoS One
- Decreased Blood Asprosin in Hyperglycemic Menopausal Women as a Result of Whole-Body Cryotherapy Regardless of Metabolic Syndrome
- (2019) Magdalena Wiecek et al. Journal of Clinical Medicine
- Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity
- (2019) Min Wang et al. ANNALS OF NUTRITION AND METABOLISM
- Sex differences in cardiometabolic disorders
- (2019) Eva Gerdts et al. NATURE MEDICINE
- Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
- (2019) Xinyue Zhang et al. Journal of Diabetes Investigation
- The Asprosin-OLFR734 hormonal signaling axis modulates male fertility
- (2019) Fangchao Wei et al. Cell Discovery
- A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin
- (2018) Ahmet Cagdas Acara et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
- (2018) Yuren Wang et al. MEDIATORS OF INFLAMMATION
- Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome
- (2018) Murat Alan et al. GYNECOLOGICAL ENDOCRINOLOGY
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- GW29-e0080 The protective role of Asprosin against diabetes in cardiomyocytes
- (2018) Jian Feng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Air Pollution and Cardiovascular Disease
- (2018) Sanjay Rajagopalan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
- (2018) Xing Li et al. MEDIATORS OF INFLAMMATION
- Gender-related issues in the pharmacology of new anti-obesity drugs
- (2018) Mauro Cataldi et al. Obesity Reviews
- Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes
- (2018) Magdalena Wiecek et al. Frontiers in Physiology
- New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
- (2018) Ting Yuan et al. Redox Biology
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- Cardiac sympathetic afferent reflex and its implications for sympathetic activation in chronic heart failure and hypertension
- (2015) W.-W. Chen et al. Acta Physiologica
- Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonist
- (2015) Angela Esposito et al. CANCER TREATMENT REVIEWS
- The Phyre2 web portal for protein modeling, prediction and analysis
- (2015) Lawrence A Kelley et al. Nature Protocols
- Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias
- (2015) R. T. Gardner et al. Nature Communications
- C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41-43
- (2014) S. A. Jensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blood Glucose Responses to Type, Intensity, Duration, and Timing of Exercise
- (2013) S. R. Colberg et al. DIABETES CARE
- The Evolution of Extracellular Fibrillins and Their Functional Domains
- (2012) Adam Piha-Gossack et al. PLoS One
- Agouti-related protein in patients with acute and weight-restored anorexia nervosa
- (2011) J. V. Merle et al. PSYCHOLOGICAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search